© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Stop me if you’ve heard this one before.
The market for therapies to treat the condition could reach as much as $35 billion dollars over the coming years.
There are currently no approved treatments for this slow, silent liver disease that may affect up to 15 million Americans.
In honor of World AIDS Day, AIDSmeds highlights the year’s top treatment stories.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
